Quarter Financials

Array BioPharma Inc.

Array BioPharma Inc. (ARRY)

$46.57
17.69 (+61.25%)

Income Statement

Balance Sheet Statement

Year 2019 Q3 2018 Q2 2018 Q1 2018 FY 2018 Q3 2017 Q2 2017 Q1 2017 FY 2017 Q3 2016 Q2 2016 Q1
Short-term debt 10.2010.8012.1012.6012.4012.7012.802.50---
Other Assets -----------
Total current liabilities 64.2164.3971.2569.5590.9273.6185.0995.9384.7784.1986.66
Cash and cash equivalents 65.8462.7883.75125.93295.4165.0573.86114.75130.51147.0996.64
Long-term debt 115.35117.54119.39121.31123.2793.2694.5693.38131.09132.65134.25
Cash and short-term investments 116.65213.93206.75234.32463.51419.27438.41412.49414.39477.06423.09
Total debt 125.55128.34131.49121.31135.67105.96107.3695.88131.09132.65134.25
Inventories -----------
Deferred revenue 9.8510.9210.3617.1616.6713.4212.4212.3511.4312.7613.63
Goodwill and Intangible Assets -----------
Total non-current liabilities 154.77155.76157.24197.87184.76147.05146.77144.69180.38179.43178.72
Total non-current assets 8.848.319.258.978.488.999.228.828.0118.1273.09
Total liabilities 218.99220.15228.49267.42275.69220.66231.86240.62265.15263.61265.38
Total assets 166.86272.20256.20279.14502.31462.85497.01460.36484.22548.96567.00
Other comprehensive income 777.72905.25916.70930.331,183.171,233.361,265.701,319.991,309.981,385.241,440.91
Short-term investments 50.81151.15123.00108.39168.09354.22364.56297.74283.89329.96326.45
Property, Plant & Equipment Net 7.257.448.498.137.587.217.557.136.866.906.98
Net Debt 59.7165.5647.74-4.63-159.7540.9133.50-18.870.59-14.4437.61
Investments 51.47151.97123.64109.12168.92355.27365.66298.66284.88331.06382.46
Total shareholders equity -52.1252.0527.7111.73226.62242.18265.15219.74219.07285.35301.63
Retained earnings (deficit) -830.00-853.32-889.07-918.70-956.70-990.71-1,000.00-1,100.00-1,090.82-1,100.00-1,139.67
Long-term investments 0.660.820.650.730.831.041.110.921.001.0956.01
Receivables -----------
Payables -----------
Total current assets 158.02263.89246.95270.18493.82453.86487.79451.54476.21530.84493.91

Cash Flow Statement

Year 2019 Q3 2018 Q2 2018 Q1 2018 FY 2018 Q3 2017 Q2 2017 Q1 2017 FY 2017 Q3 2016 Q2 2016 Q1
Operating Cash Flow -14.61-27.61-14.4517.26-18.04-52.13-20.98-28.63-34.80-8.64-43.99
Free Cash Flow -15.65-28.29-16.0217.05-18.07-52.32-21.89-28.74-35.06-9.22-44.60
Capital Expenditure 1.050.691.570.210.020.190.910.110.270.580.61
Depreciation & Amortization 2.292.362.402.482.542.241.851.861.972.102.13
Acquisitions and disposals -----------
Deferred income taxes -----------
Investment purchases -46.18-151.33-153.92-36.12-104.47-233.59-57.31-47.23-87.31-234.10-156.05
Accounts payables -3.35-0.242.510.081.291.251.751.434.27-6.101.39
Sales/Maturities of investments 48.7050.80182.2650.6844.7546.6746.82114.56101.28-101.28306.98
Change in working capital -9.06105.70-23.8024.93202.27-22.6622.46-47.0935.8355.21-39.40
Debt repayment -0.12-14.43----4.31-----
Other non-cash items -----------
Investing Cash Flow 1.47-101.2227.2914.35-59.75-187.10-11.4067.2113.74-46.69-51.64
Cash at beginning of period 56.6065.8462.7883.75125.93295.4165.0573.86114.75130.51147.09
Stock-based compensation 1.912.102.893.075.583.244.725.574.815.538.32
Net cash flow / Change in cash 9.24-3.0620.9642.18169.48-230.368.8040.8915.7616.59-50.46
Effect of forex changes on cash -----------
Financing Cash Flow 22.38125.778.1310.53247.278.8741.182.3136.8271.9145.17
Dividend payments -----------
Accounts receivables 5.36-9.1810.621.234.68-3.37-14.1912.07-12.2922.13-9.41
Cash at end of period 65.8462.7883.75125.93295.4165.0573.86114.75130.51147.0996.64
Net cash provided by operating activities -14.61-27.61-14.4517.26-18.04-52.13-20.98-28.63-34.80-8.64-43.99
Other working capital 93.81199.50175.70200.63402.90380.24402.70355.61391.44446.65407.25
Inventory -----------

Retained Earning Schedule

Year 2016 Q1 2016 Q2 2017 Q3 2017 FY 2017 Q1 2017 Q2 2018 Q3 2018 FY 2018 Q1 2018 Q2 2019 Q3
Net Income -29-23-35-30-38-34-23-52-25-11-37
Dividend Paid -----------
Retained Earnings -830-853-889-919-957-991-1,000-1,100-1,091-1,100-1,140

PPE Schedule

Year 2016 Q1 2016 Q2 2017 Q3 2017 FY 2017 Q1 2017 Q2 2018 Q3 2018 FY 2018 Q1 2018 Q2 2019 Q3
Capital Expenditure 11200010011
Net PPE 77888787777

Intangible and Goodwill Schedule

Year 2016 Q1 2016 Q2 2017 Q3 2017 FY 2017 Q1 2017 Q2 2018 Q3 2018 FY 2018 Q1 2018 Q2 2019 Q3
New Purchases -46-151-154-36-104-234-57-47-87-234-156
Intangible and Goodwill -----------